Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia.
BMJ Open Gastroenterol
; 10(1)2023 04.
Article
in English
| MEDLINE | ID: covidwho-2291082
ABSTRACT
BACKGROUND:
Hepatic damage is one of the common forms of extra pulmonary organ destructions among patients with COVID-19 infections.AIM:
To evaluate the prognosis of liver damage among COVID-19 patients based on their liver enzymes profile.METHODS:
A retrospective study was done to evaluate the records of the hospitably admitted patient due to COVID-19 infection.Retrieved data included clinical presentation and investigation either imaging or laboratory with special investing in liver function tests.RESULT:
We reviewed 442 patients who were diagnosed with COVID-19 infection.They were 64.5% of female patients and 35.5% of male patients. Their mean age was 54.5%, most of them were Saudi (76.7%) and the overall mortality reached up to (20.4%).CONCLUSION:
This large cohort of 442 patients has shown that liver damage may be an independent prognostic factor for morbidities and mortality among COVID-19 patients. It also showed the importance of liver function enzymes screening as a predictor for the outcome of those patients.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Liver Diseases
Type of study:
Cohort study
/
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
English
Year:
2023
Document Type:
Article
Affiliation country:
Bmjgast-2023-001121
Similar
MEDLINE
...
LILACS
LIS